Javascript must be enabled to continue!
Posttransfusion purpura‐like syndrome associated with CD36 (Naka) isoimmunization
View through CrossRef
BACKGROUND: CD36 deficiency, which could lead to CD36 isoimmunization, has been reported in the Japanese population. CD36 isoantibody has been involved in platelet transfusion refractoriness. CASE REPORT: A 50‐year‐ old woman originally from Corsica developed severe acute thrombocytopenia after massive transfusion. She was found to be CD36 deficient, and platelet immunoassays revealed a CD36 (Naka) platelet isoantibody. Although the involvement of another mechanism could not be entirely ruled out, the thrombocytopenia was attributed to posttransfusion purpura‐like syndrome. The antibody was also involved in platelet transfusion refractoriness. CD36 deficiency was present in two members of the patient's family as well. Flow cytometry studies demonstrated the absence of CD36 expression on the surface of blood monocytes and cultured erythroblasts and megakaryocytes from one of the two CD36‐deficient family members studied, but, in the absence of previous immunization, these CD36‐deficient patients were not isoimmunized. In contrast, CD36 deficiency was not found in a population of 808 healthy blood donors in the Paris, France, area.CONCLUSION: CD36 isoantibody might be involved in some cases of posttransfusion purpura and platelet transfusion refractoriness. These findings also confirm the extremely low frequency of CD36 deficiency among whites.
Title: Posttransfusion purpura‐like syndrome associated with CD36 (Naka) isoimmunization
Description:
BACKGROUND: CD36 deficiency, which could lead to CD36 isoimmunization, has been reported in the Japanese population.
CD36 isoantibody has been involved in platelet transfusion refractoriness.
CASE REPORT: A 50‐year‐ old woman originally from Corsica developed severe acute thrombocytopenia after massive transfusion.
She was found to be CD36 deficient, and platelet immunoassays revealed a CD36 (Naka) platelet isoantibody.
Although the involvement of another mechanism could not be entirely ruled out, the thrombocytopenia was attributed to posttransfusion purpura‐like syndrome.
The antibody was also involved in platelet transfusion refractoriness.
CD36 deficiency was present in two members of the patient's family as well.
Flow cytometry studies demonstrated the absence of CD36 expression on the surface of blood monocytes and cultured erythroblasts and megakaryocytes from one of the two CD36‐deficient family members studied, but, in the absence of previous immunization, these CD36‐deficient patients were not isoimmunized.
In contrast, CD36 deficiency was not found in a population of 808 healthy blood donors in the Paris, France, area.
CONCLUSION: CD36 isoantibody might be involved in some cases of posttransfusion purpura and platelet transfusion refractoriness.
These findings also confirm the extremely low frequency of CD36 deficiency among whites.
Related Results
Abstract 1732: Functional characterization of the impact of CD36 deletion on normal hematopoiesis and the leukemia microenvironment
Abstract 1732: Functional characterization of the impact of CD36 deletion on normal hematopoiesis and the leukemia microenvironment
Abstract
CD36 has been identified as a potential therapeutic target both in the leukemic cells and in the tumor immune microenvironment. CD36 also plays a role in li...
Foamy Monocytes Form Early and Contribute to Nascent Atherosclerosis in Mice With Hypercholesterolemia
Foamy Monocytes Form Early and Contribute to Nascent Atherosclerosis in Mice With Hypercholesterolemia
Objective—
To examine infiltration of blood foamy monocytes, containing intracellular lipid droplets, into early atherosclerotic lesions and its contribution to develop...
TRPM2 deficiency protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages
TRPM2 deficiency protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages
ABSTRACT
Atherosclerosis is the major cause of ischemic heart diseases and ischemic brain stroke, which are the leading causes of mortality world...
Abstract 5193: A subpopulation of circulating epithelial tumor cells positive for fatty acid receptor CD36 is linked to aggressiveness of breast cancer disease
Abstract 5193: A subpopulation of circulating epithelial tumor cells positive for fatty acid receptor CD36 is linked to aggressiveness of breast cancer disease
Abstract
Background: Breast cancer is one of the leading causes of cancer death for women worldwide. Major hurdles for a successful treatment are cancer metastases, ...
CD36 mRNA and Protein Expression Levels Are Significantly Increased in the Heart and Testis of apoE Deficient Mice in Comparison to Wild Type (C57BL/6)
CD36 mRNA and Protein Expression Levels Are Significantly Increased in the Heart and Testis of apoE Deficient Mice in Comparison to Wild Type (C57BL/6)
CD36, an 88kd‐adhesion molecule, plays a major role as a scavenging receptor implicated in cellular lipid metabolism. Secretory mammary epithelium, microvasculature endothelium, ad...
Henoch-Schonlein Purpura (HSP)
Henoch-Schonlein Purpura (HSP)
Abstract—Henoch-Schonlein purpura (HSP) is a systemic vasculitic disease (vascular inflammation) characterized by the deposition of immune complexes consisting of IgA in kidney ski...
The role of CD36 in cardiovascular diseases
The role of CD36 in cardiovascular diseases
CD36, also known as scavenger receptor B2, is a multifunctional receptor
widely expressed in various organs. CD36 plays a crucial role in the
uptake of long-chain fatty acids, the ...
Hemoglobin a1c induced down-regulation of CD36 of Plasmodium falciparum parasitized red cell
Hemoglobin a1c induced down-regulation of CD36 of Plasmodium falciparum parasitized red cell
High values of glycosylated hemoglobin have been found to correlate with decreased deformability of erythrocyte. CD36 (Cluster of Differentiation 36) is an integral membrane protei...

